New policy from Government funders of clinical
trials
In February
2026, the NHMRC and the Department of Health, Disability and Ageing released a joint
Open Science Policy outlining the expectation
that clinical trial results are shared publicly in a timely way. It states:
“NHMRC and Medical Research Future Fund expect
the timely sharing of results from clinical trials, ideally within 12 months
from primary study completion….in a clinical registry such as ANZCTR.”1
The policy explains
that making clinical trial results publicly accessible helps ensure that public
investment in health and medical research delivers the greatest possible
benefit to society. This approach
aligns with the New Zealand Health Research Council’s (NZ HRC) Clinical
Trials Policy2 and World Health Organization recommendations3,4.
The ANZCTR has previously outlined the benefits of making trial results,
protocols and related documents publicly available5.
What does
this mean for trial investigators?
The ANZCTR can support trial investigators to comply with the policy:
✔ at
no cost
✔ without compromising future journal
publications
✔ regardless of whether results
are published or unpublished, and
✔ regardless of the format of the
results write-up
Options
for trial investigators are:
|
When to use this
|
Step 1: Options for trial investigators
|
Step 2: Actions on the ANZCTR
|
Impact on journal publication
|
|
Compliance
|
Upload summary results to a clinical trials registry
|
Upload summary results table using the ANZCTR template to the registry including:
- Participant flow
- Baseline characteristics
- Key outcomes & adverse events
|
✔ Accepted by ICMJE‑aligned journals and
has been an ICMJE agreed policy since 20186
Uploading summary results to the ANZCTR is not considered prior
publication by journals. This approach is now standard practice for most
journals
|
|
Draft yet unpublished manuscript
|
Upload manuscript to a reputable preprint server, e.g. medRxiv
|
Update the registry record with: - DOI(s) or links
to pre- prints
|
✔
Usually accepted by journals though trial investigators
should confirm policies of preferred journal before using pre-print servers
Many journals allow pre-prints
if disclosed at submission
|
|
Journal publication is: Delayed
Under review OR Does not report all outcomes (e.g.
secondary)
|
Upload summary results to a clinical trials registry
|
Upload results table using the ANZCTR template to include all pre-specified outcomes
|
✔ Accepted by ICMJE‑aligned journals6
Uploading summary results to the ANZCTR is not considered prior
publication by journals. This approach is now standard practice for most
journals
|
|
Access to all trial outputs in the one place for the public
|
Link publications and outputs provided in pre-prints or institutional
repositories to the trial registry record
|
Update the registry record with:
- DOI(s) of
published articles
- DOI(s) or links
to pre-prints or institutional repositories
- Files where
permitted by copyright
|
✔ …
though trial investigators should check embargo period before
uploading journal publication to an institutional repository
|
|
Create findable trial outputs with low administrative burden on trial
investigator
|
Use the ACTRN across all trial outputs
|
Include the ACTRN in:
- Protocols and
SAPs
- Conference
proceedings
- Pre-prints and journal manuscripts
|
Not applicable
Allows the ANZCTR to automatically link trial outputs within the trial
registry record
|
Summary
Australian and New Zealand governments and international organisations
expect trial results and related materials to be publicly accessible,
regardless of publication status or trial outcomes. The ANZCTR provides practical
options to help trial investigators meet these requirements without compromising
future journal publications.
1NHMRC and MRFF Open Science Policy. Available at: https://www.nhmrc.gov.au/about-us/resources/nhmrc-and-mrff-open-science-policy#toc__319
New
Zealand Health Research Council (NZ HRC). Clinical Trial Transparency Policy
statement. 2020. Available at: https://www.hrc.govt.nz/sites/default/files/2020-07/HRC%20CT%20transparency%20policy.pdf
World
Health Organization. Joint statement on public disclosure of results from
clinical trials. 2017. Available at: https://www.who.int/news/item/18-05-2017-joint-statement-on-registration
4Chan et al. Reporting summary results in clinical trial
registries: updated guidance from WHO. 2025. The Lancet, Global Health.
DOI: 10.1016/S2214-109X(24)00514-X
ANZCTR
News: Maximising the impact of every clinical trial using the ANZCTR. 2025.
Available at: ANZCTR
ICMJE.
Recommendations for the conduct, reporting, editing, and publication of
scholarly work in medical journals. 2026. Available at: CP-ACPJ220177 1..21